No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The AIDS Associated Dementia Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat HIV-associated dementia, a neurological disorder caused by HIV infection. These drugs are used to reduce the symptoms of dementia, such as memory loss, confusion, and difficulty concentrating. They can also help to improve cognitive functioning and reduce the risk of further cognitive decline. Common drugs used in this market include antiretroviral drugs, anticonvulsants, and antipsychotics.
Some companies in the AIDS Associated Dementia Drug market include Gilead Sciences, Merck & Co., Bristol-Myers Squibb, and Pfizer. Other companies include GlaxoSmithKline, Johnson & Johnson, and AbbVie. Show Less Read more
